|
Evolving racial/ethnic disparities in AML survival in the novel therapy era
|
January 31, 2025
|
PC3I Authors Catherine Lai; Ronac Mamtani |
Blood Advances
|
|
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
|
April 18, 2024
|
PC3I Authors Catherine Lai |
Haematologica
|
|
Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach
|
March 27, 2024
|
PC3I Authors Catherine Lai |
Leukemia & Lymphoma
|
|
Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia
|
September 9, 2021
|
PC3I Authors Catherine Lai |
Hematological Oncology
|
|
Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic
|
March 1, 2022
|
PC3I Authors Catherine Lai |
Journal of Oncology
|
|
Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
|
June 22, 2022
|
PC3I Authors Catherine Lai |
Clinical Advances in Hematology and Oncology
|
|
The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?
|
July 18, 2022
|
PC3I Authors Catherine Lai |
EJHaem
|
|
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
|
July 26, 2022
|
PC3I Authors Catherine Lai |
Blood Advances
|
|
TP53 in AML and MDS: The new (old) kid on the block
|
February 25, 2023
|
PC3I Authors Catherine Lai |
Blood Reviews
|
|
Recent advances in targeted therapies in acute myeloid leukemia
|
March 25, 2023
|
PC3I Authors Catherine Lai |
Journal of Hematology & Oncology
|
|
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis
|
April 24, 2023
|
PC3I Authors Catherine Lai |
Annals of Hematology
|
|
Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician
|
May 8, 2023
|
PC3I Authors Catherine Lai |
American Society of Clinical Oncology Educucational Book
|
|
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
|
May 15, 2023
|
PC3I Authors Catherine Lai |
Cancer
|
|
Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia
|
May 31, 2023
|
PC3I Authors Catherine Lai |
Cancer
|
|
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
|
June 19, 2023
|
PC3I Authors Catherine Lai |
American Journal of Hematology
|
|
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
|
August 31, 2023
|
PC3I Authors Michelle Iocolano; Catherine Lai; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
|
November 1, 2023
|
PC3I Authors Catherine Lai |
Transplantation and Cellular Therapy
|
|
Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies
|
January 5, 2024
|
PC3I Authors Catherine Lai |
Blood Reviews
|
|
Influence of Income, Education, and Medicaid Expansion on Palliative Care in Acute Myeloid Leukemia Using the National Cancer Database
|
January 13, 2024
|
PC3I Authors Catherine Lai |
Journal of Pain and Symptom Management
|
|
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial
|
March 13, 2024
|
PC3I Authors Catherine Lai |
Cancers
|
